Privia Health Group Stock Investor Sentiment

PRVA Stock  USD 22.45  0.89  4.13%   
About 60% of all Privia Health's investors are looking to take a long position. The analysis of overall sentiment of trading Privia Health Group stock suggests that some investors are interested at this time. The current market sentiment, together with Privia Health's historical and current headlines, can help investors time the market. In addition, many technical investors use Privia Health Group stock news signals to limit their universe of possible portfolio assets.
  

Privia Health Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Privia Health can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over six months ago at news.google.com         
Privia Health Group, Inc. Shares Sold by Mirae Asset Global Investments Co. Ltd. - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Bleakley Financial Group LLC Makes New Investment in Privia Health Group, Inc. - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Privia Health Group, Inc. Shares Sold by Peregrine Capital Management LLC - MarketBeat
Google News at Macroaxis
over six months ago at globenewswire.com         
Privia Health to Report First Quarter 2024 Results on Thursday, May 9
Macroaxis News: globenewswire.com
over six months ago at simplywall.st         
Privia Health Group, Inc.s Fundamentals Look Pretty Strong Could The Market Be Wrong About The Stock...
Simply Wall St News at Macroaxis
over six months ago at news.google.com         
Privia Health Group, Inc. Given Consensus Rating of Moderate Buy by Analysts - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Advisors Preferred LLC Makes New Investment in Privia Health Group, Inc. - MarketBeat
Google News at Macroaxis
over six months ago at investing.com         
Privia Health CFO sells over 69k in company stock
Investing News at Macroaxis
over six months ago at www.macroaxis.com         
Disposition of 33 shares by Mountcastle David of Privia Health at 17.77 subject to Rule 16b-3
Macroaxis News
over six months ago at news.google.com         
Privia Health Group, Inc. Position Boosted by Vanguard Group Inc. - MarketBeat
Google News at Macroaxis
over six months ago at www.macroaxis.com         
Discretionary transaction by Boehler Adam of tradable shares of Privia Health subject to Rule 16b-3
Macroaxis News
over six months ago at news.google.com         
Privia Health Group Sets New 1-Year Low at 19.03 - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Privia Health Group Trading Down 4.5 percent - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Privia Health Group Given New 37.00 Price Target at Canaccord Genuity Group - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Privia Health Group Price Target Cut to 37.00 - MarketBeat
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Privia Health that are available to investors today. That information is available publicly through Privia media outlets and privately through word of mouth or via Privia internal channels. However, regardless of the origin, that massive amount of Privia data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Privia Health news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Privia Health relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Privia Health's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Privia Health alpha.

Privia Health Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Privia Health Group Shares Cross Below 200 DMA - Nasdaq
09/03/2024
2
Disposition of 18595 shares by Parth Mehrotra of Privia Health at 2.0 subject to Rule 16b-3
09/10/2024
3
Disposition of 16144 shares by Parth Mehrotra of Privia Health at 2.0 subject to Rule 16b-3
09/11/2024
4
Lower Instruments Sales to Hurt TXG Q3 Earnings, Prelim Sales Down
10/28/2024
5
Acquisition by Mccarthy Thomas A of 7758 shares of Privia Health subject to Rule 16b-3
10/29/2024
6
Privia Health Group Inc Shares Up 5.45 percent on Oct 30
10/30/2024
7
There Are Reasons To Feel Uneasy About Privia Health Groups Returns On Capital
11/04/2024
8
Clover Health Investments, Corp. Reports Q3 Loss, Lags Revenue Estimates
11/06/2024
9
Compared to Estimates, Privia Health Q3 Earnings A Look at Key Metrics
11/07/2024
10
Privia Health Group Inc Q3 2024 Earnings Call Highlights Strong Financial Performance ...
11/08/2024
11
Disposition of 10634 shares by Thomas Bartrum of Privia Health at 26.3 subject to Rule 16b-3
11/12/2024
12
Some May Be Optimistic About Privia Health Groups Earnings
11/14/2024
13
Disposition of 2320 shares by Mountcastle David of Privia Health at 18.42 subject to Rule 16b-3
11/25/2024

Complementary Tools for Privia Stock analysis

When running Privia Health's price analysis, check to measure Privia Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Privia Health is operating at the current time. Most of Privia Health's value examination focuses on studying past and present price action to predict the probability of Privia Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Privia Health's price. Additionally, you may evaluate how the addition of Privia Health to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.